Research Glaucoma Artificial Intelligence (AI)
Large language models (LLMs), such as ChatGPT, have skyrocketed in popularity in the last year due to their ability to utilize vast amounts of information, but could they be used to diagnose ocular disease?
Innovation Patient Care Glaucoma
About once a month, Deidre St. Peter, MD, assistant professor of ophthalmology at the University of Colorado School of Medicine, performs a XEN Gel Stent surgery, implanting a tiny tube-like structure into the eye to reduce pressure and prevent vision loss associated with open-angle glaucoma.
Ram Nagaraj, PhD, professor in the University of Colorado Department of Ophthalmology, envisions a future where ophthalmologists can prevent vision loss associated with glaucoma, the second leading cause of blindness in the world.
Innovation Clinical Research Cataracts Glaucoma
A new drug delivery platform developed by Malik Y. Kahook, MD, professor of ophthalmology and the Slater Family Endowed Chair in Ophthalmology at the University of Colorado School of Medicine, shows promise for the future of glaucoma care after six months of follow up in the first human study.
Awareness Glaucoma Diabetic retinopathy Equity Diversity and Inclusion
Although Black Americans are the second-largest minority population in the United States, they remain underrepresented in vision health research. They also carry the highest burden of eye disease ranging from general visual impairment to glaucoma, diabetic retinopathy, and blindness.
Patient Care Advancement Cataracts Glaucoma
Philip Tarlow’s inspiration to pursue art was sparked at an early age. He recalls a kindergarten teacher noticing his fascination with construction workers, which ultimately became the subject matter of his creations 30 years later.
Procedures to alleviate eye pressure associated with blinding diseases such as glaucoma date back over a century. Although glaucoma, a condition that damages the eye’s optic nerve, allows for a number of treatment options prior to surgery, including drops and lasers, research has shown traditional surgical techniques could result in higher risks of vision complications, longer recovery times, and higher associated costs. Identifying this disconnect, Malik Y. Kahook, MD, professor of ophthalmology and the Slater Family Endowed Chair in Ophthalmology at the University of Colorado School of Medicine, sought out a more accessible and practical solution to propel glaucoma treatment into the 21st century.
Physician's Weekly
November 13, 2023
Brain tumor segmentations are integral to the clinical management of patients with glioblastoma, the deadliest primary brain tumor in adults, Jayashree Kalpathy-Cramer, PhD, professor of ophthalmology at the University of Colorado School of Medicine, and other researchers write in findings on experts’ perceptions of segmentation quality that will allow the design of improved frameworks for expert-centered evaluation of brain tumor segmentation models.
Ophthalmology Times
November 13, 2023
Jayashree Kalpathy-Cramer, PhD, was granted $300,000 from the Michael J Fox Foundation to examine key data put together at the Sue Anschutz-Rodgers Eye Center with artificial intelligence in an effort to identify biomarkers of Parkinson’s disease.
Barron's
November 09, 2023
“This is a huge deal,” Kia Washington, MD, a professor of surgery and secondary DOO faculty member at University of Colorado Anschutz Medical Campus, who has been working in the same field for 15 years, told AFP, commending her peers.
Glaucoma Today
November 03, 2023
Cara Capitena Young, MD, assistant professor of ophthalmology at the Sue Anschutz-Rodgers Eye Center, was featured in the September/October edition of Glaucoma Today's Case Files and weighs in on how she would proceed after intraoperative malignant glaucoma derails cataract surgery.
Kara Mason
